KDT-500

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameKDT-500
Drug Alias NameKDT-500
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonistsFree fatty acid receptor 4 agonists
TargetsPeroxisome proliferator-activated receptor γFree fatty acid receptor 4
Therapy Area/IndicationsInflammationDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKindex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKindex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A